Alzheimer’s disease has no doubt existed throughout human history. Early diagnosis can slow the progress of this mind-stealing malady, but no cure has been found. Recently a new drug shows promise in early trials. The drug cleared toxic proteins from affected brains. The higher the dose of the antibody, the more amyloid plaque vanished.
The antibody is based on an immune cell from elderly people who show no Alzheimer’s symptoms. The findings support the view that plaque is part of the cause of the disease rather than a byproduct as some scientists believe.
The scientists from Biogen and Neurimmune call the study unprecedented but also are trying not to get too excited. Other drugs have shown promise in phase 1 trials, but failed to pan out.
Larger trials are underway. I hope they prove the effectiveness of the drug and that it’s not too late for me. My loss of memory is odd. I don’t forget to do things. I forget I’ve done them and try to do them twice. There is a distinction between garden-variety memory loss as one ages and Alzheimer’s. Misplacing keys is ordinary. Not remembering what keys are for is an Alzheimer’s symptom. So far, so good.
The drug is called aducanumab. The name is curious. It seems a mix of meaningful syllables. I could not find the source. Anyone better at searching?
Photo and adaptation from: